These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 11716839)

  • 1. Peroxisome proliferator-activated receptor delta is a specific sensor for teratogenic valproic acid derivatives.
    Lampen A; Carlberg C; Nau H
    Eur J Pharmacol; 2001 Nov; 431(1):25-33. PubMed ID: 11716839
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prediction of embryotoxic effects of valproic acid-derivatives with molecular in vitro methods.
    Lampen A; Göttlicher M; Nau H
    ALTEX; 2001; 18(2):123-6. PubMed ID: 11378687
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New molecular bioassays for the estimation of the teratogenic potency of valproic acid derivatives in vitro: activation of the peroxisomal proliferator-activated receptor (PPARdelta).
    Lampen A; Siehler S; Ellerbeck U; Göttlicher M; Nau H
    Toxicol Appl Pharmacol; 1999 Nov; 160(3):238-49. PubMed ID: 10544058
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of differentiation in F9 cells and activation of peroxisome proliferator-activated receptor delta by valproic acid and its teratogenic derivatives.
    Werling U; Siehler S; Litfin M; Nau H; Göttlicher M
    Mol Pharmacol; 2001 May; 59(5):1269-76. PubMed ID: 11306712
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulation of peroxisome proliferator-activated receptor delta activity affects neural cell adhesion molecule and polysialyltransferase ST8SiaIV induction by teratogenic valproic acid analogs in F9 cell differentiation.
    Lampen A; Grimaldi PA; Nau H
    Mol Pharmacol; 2005 Jul; 68(1):193-203. PubMed ID: 15829700
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nuclear receptor corepressor-dependent repression of peroxisome-proliferator-activated receptor delta-mediated transactivation.
    Krogsdam AM; Nielsen CA; Neve S; Holst D; Helledie T; Thomsen B; Bendixen C; Mandrup S; Kristiansen K
    Biochem J; 2002 Apr; 363(Pt 1):157-65. PubMed ID: 11903058
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A regulatory role for RIP140 in nuclear receptor activation.
    Treuter E; Albrektsen T; Johansson L; Leers J; Gustafsson JA
    Mol Endocrinol; 1998 Jun; 12(6):864-81. PubMed ID: 9626662
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of gene transcription by prostacyclin analogues is mediated by the peroxisome-proliferators-activated receptor (PPAR).
    Hertz R; Berman I; Keppler D; Bar-Tana J
    Eur J Biochem; 1996 Jan; 235(1-2):242-7. PubMed ID: 8631336
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Teratogenic phthalate esters and metabolites activate the nuclear receptors PPARs and induce differentiation of F9 cells.
    Lampen A; Zimnik S; Nau H
    Toxicol Appl Pharmacol; 2003 Apr; 188(1):14-23. PubMed ID: 12668118
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PPAR gamma/RXR as a molecular target for diabetes.
    Lenhard JM
    Recept Channels; 2001; 7(4):249-58. PubMed ID: 11697231
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Terminal differentiation of human liposarcoma cells induced by ligands for peroxisome proliferator-activated receptor gamma and the retinoid X receptor.
    Tontonoz P; Singer S; Forman BM; Sarraf P; Fletcher JA; Fletcher CD; Brun RP; Mueller E; Altiok S; Oppenheim H; Evans RM; Spiegelman BM
    Proc Natl Acad Sci U S A; 1997 Jan; 94(1):237-41. PubMed ID: 8990192
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting peroxisome proliferator-activated receptors (PPARs) in kidney and urologic disease.
    Guan Y
    Minerva Urol Nefrol; 2002 Jun; 54(2):65-79. PubMed ID: 12185990
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synergistic potentiation of thiazolidinedione-induced ST 13 preadipocyte differentiation by RAR synergists.
    Sato M; Yajima Y; Kawashima S; Tanaka K; Kagechika H
    Biochem Biophys Res Commun; 2001 Jan; 280(3):646-51. PubMed ID: 11162570
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ligands for the peroxisome proliferator-activated receptor-gamma and the retinoid X receptor-alpha exert synergistic antiproliferative effects on human coronary artery smooth muscle cells.
    Benson S; Padmanabhan S; Kurtz TW; Pershadsingh HA
    Mol Cell Biol Res Commun; 2000 Mar; 3(3):159-64. PubMed ID: 10860864
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transactivation by PPAR/RXR heterodimers in yeast is potentiated by exogenous fatty acid via a pathway requiring intact peroxisomes.
    Marcus SL; Miyata KS; Rachubinski RA; Capone JP
    Gene Expr; 1995; 4(4-5):227-39. PubMed ID: 7787415
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Addition of peroxisome proliferator-activated receptor alpha to guinea pig hepatocytes confers increased responsiveness to peroxisome proliferators.
    Macdonald N; Holden PR; Roberts RA
    Cancer Res; 1999 Oct; 59(19):4776-80. PubMed ID: 10519382
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antagonism of COUP-TF and PPAR alpha/RXR alpha on the activation of the malic enzyme gene promoter: modulation by 9-cis RA.
    Baes M; Castelein H; Desmet L; Declercq PE
    Biochem Biophys Res Commun; 1995 Oct; 215(1):338-45. PubMed ID: 7575611
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A retinoid X receptor (RXR)-selective retinoid reveals that RXR-alpha is potentially a therapeutic target in breast cancer cell lines, and that it potentiates antiproliferative and apoptotic responses to peroxisome proliferator-activated receptor ligands.
    Crowe DL; Chandraratna RA
    Breast Cancer Res; 2004; 6(5):R546-55. PubMed ID: 15318936
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Valproic acid induces CYP3A4 and MDR1 gene expression by activation of constitutive androstane receptor and pregnane X receptor pathways.
    Cerveny L; Svecova L; Anzenbacherova E; Vrzal R; Staud F; Dvorak Z; Ulrichova J; Anzenbacher P; Pavek P
    Drug Metab Dispos; 2007 Jul; 35(7):1032-41. PubMed ID: 17392393
    [TBL] [Abstract][Full Text] [Related]  

  • 20. mPPAR gamma 2: tissue-specific regulator of an adipocyte enhancer.
    Tontonoz P; Hu E; Graves RA; Budavari AI; Spiegelman BM
    Genes Dev; 1994 May; 8(10):1224-34. PubMed ID: 7926726
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.